PlumeStop
Commercial- Indications
- PFAS contamination, Groundwater contamination
Company intelligence / Profile preview
Regenesis
Canadaregenesisbiotech.ca ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Regenesis Biotech offers commercial services in genetic testing for disease predisposition and dental pulp stem cell banking. They highlight the utility of early detection of high-risk genes such as BRCA1/2 and promote the future therapeutic potential of stored dental pulp mesenchymal stem cells. The company emphasizes accessibility and affordability in advanced healthcare solutions.
- Therapeutic areas
- OtherOncologyHematology
- Modalities
- Genetic testing serviceStem cell therapyExosome-based therapy
- Industry
- Molecular Diagnostics
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Regenesis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regenesis.